Annual EBIT:
-$223.61M-$76.84M(-52.36%)Summary
- As of today, KYMR annual earnings before interest & taxes is -$223.61 million, with the most recent change of -$76.84 million (-52.36%) on December 31, 2024.
- During the last 3 years, KYMR annual EBIT has fallen by -$123.57 million (-123.52%).
- KYMR annual EBIT is now -942.42% below its all-time high of -$21.45 million, reached on December 31, 2018.
Performance
KYMR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$88.67M-$4.11M(-4.86%)Summary
- As of today, KYMR quarterly earnings before interest & taxes is -$88.67 million, with the most recent change of -$4.11 million (-4.86%) on September 30, 2025.
- Over the past year, KYMR quarterly EBIT has dropped by -$16.54 million (-22.94%).
- KYMR quarterly EBIT is now -996.94% below its all-time high of -$8.08 million, reached on September 30, 2020.
Performance
KYMR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$328.40M-$16.54M(-5.30%)Summary
- As of today, KYMR TTM earnings before interest & taxes is -$328.40 million, with the most recent change of -$16.54 million (-5.30%) on September 30, 2025.
- Over the past year, KYMR TTM EBIT has dropped by -$133.14 million (-68.18%).
- KYMR TTM EBIT is now -2668.77% below its all-time high of -$11.86 million, reached on September 30, 2019.
Performance
KYMR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KYMR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -52.4% | -22.9% | -68.2% |
| 3Y3 Years | -123.5% | -97.5% | -109.7% |
| 5Y5 Years | -442.7% | -996.9% | -624.9% |
KYMR EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -123.5% | at low | -359.1% | at low | -109.7% | at low |
| 5Y | 5-Year | -442.7% | at low | -996.9% | at low | -624.9% | at low |
| All-Time | All-Time | -942.4% | at low | -996.9% | at low | -2668.8% | at low |
KYMR EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$88.67M(-4.9%) | -$328.40M(-5.3%) |
| Jun 2025 | - | -$84.56M(-13.6%) | -$311.86M(-12.1%) |
| Mar 2025 | - | -$74.43M(+7.8%) | -$278.23M(-8.4%) |
| Dec 2024 | -$223.61M(-52.4%) | -$80.75M(-12.0%) | -$256.71M(-31.5%) |
| Sep 2024 | - | -$72.12M(-41.6%) | -$195.27M(-8.1%) |
| Jun 2024 | - | -$50.92M(+3.7%) | -$180.65M(-4.4%) |
| Mar 2024 | - | -$52.91M(-174.0%) | -$173.11M(-4.6%) |
| Dec 2023 | -$146.77M(+5.1%) | -$19.31M(+66.4%) | -$165.53M(+10.5%) |
| Sep 2023 | - | -$57.51M(-32.6%) | -$184.85M(-7.3%) |
| Jun 2023 | - | -$43.38M(+4.3%) | -$172.22M(-1.5%) |
| Mar 2023 | - | -$45.33M(-17.3%) | -$169.65M(-5.2%) |
| Dec 2022 | -$154.63M | -$38.63M(+13.9%) | -$161.26M(-3.0%) |
| Sep 2022 | - | -$44.88M(-10.0%) | -$156.62M(-11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$40.81M(-10.5%) | -$140.38M(-12.9%) |
| Mar 2022 | - | -$36.93M(-8.6%) | -$124.30M(-23.6%) |
| Dec 2021 | -$100.04M(-120.0%) | -$33.99M(-18.7%) | -$100.53M(-26.7%) |
| Sep 2021 | - | -$28.64M(-15.8%) | -$79.32M(-35.0%) |
| Jun 2021 | - | -$24.73M(-87.8%) | -$58.76M(-21.9%) |
| Mar 2021 | - | -$13.17M(-3.0%) | -$48.23M(-4.2%) |
| Dec 2020 | -$45.48M(-10.4%) | -$12.78M(-58.1%) | -$46.30M(-2.2%) |
| Sep 2020 | - | -$8.08M(+43.0%) | -$45.30M(+7.7%) |
| Jun 2020 | - | -$14.19M(-26.2%) | -$49.08M(-40.7%) |
| Mar 2020 | - | -$11.25M(+4.5%) | -$34.89M(-47.6%) |
| Dec 2019 | -$41.20M(-92.1%) | -$11.78M(+0.7%) | -$23.64M(-99.3%) |
| Sep 2019 | - | -$11.86M | -$11.86M |
| Dec 2018 | -$21.45M | - | - |
FAQ
- What is Kymera Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual EBIT year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Kymera Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. TTM EBIT year-on-year change?
What is Kymera Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of KYMR is -$223.61M
What is the all-time high annual EBIT for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$21.45M
What is Kymera Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, KYMR annual earnings before interest & taxes has changed by -$76.84M (-52.36%)
What is Kymera Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of KYMR is -$88.67M
What is the all-time high quarterly EBIT for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$8.08M
What is Kymera Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, KYMR quarterly earnings before interest & taxes has changed by -$16.54M (-22.94%)
What is Kymera Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of KYMR is -$328.40M
What is the all-time high TTM EBIT for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$11.86M
What is Kymera Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, KYMR TTM earnings before interest & taxes has changed by -$133.14M (-68.18%)